Staff monitored and recorded the pulse rate, oral temperature, blood pressure and subjects well-being during check-in at 00.00 (pre-dose), 03.00, 09.00, 32.00, 54.00, 74.00 and 95.00-hours post-dose, poststudy and at the discretion of the clinical staff
Under current FDA guidance, a 503A pharmacy can compound a GLP-1 medication for a specific patient only when the prescriber documents a "significant difference" - a genuine clinical reason why the compounded formulation serves that patient's specific medical need in a way the commercially available FDA-approved product cannot
One of the most anticipated potential health benefits of retatrutide lies in its possible impact on cardiovascular and liver health , two areas of significant unmet need in people living with obesity and metabolic disease
Mochis CEO, Dr
Dosage adjustments may be necessary
Dehydration can worsen common GLP-1 side effects like fatigue, dizziness, and constipation